top of page
VexFarm PNG.jpg
Happy Family Outdoors

"VaxFarm is an Australian biotechnology company founded to combat emerging infectious diseases."

VaxFarm is redefining vaccine development with cutting-edge research aimed at tackling infectious diseases, advancing both human and animal health.

Our Vision Forward

At VaxFarm, we dedicate ourselves to developing groundbreaking vaccines that address the health needs of communities globally. Our team of experts drives innovation in biotechnology.

  • Future-Proofing Global Health

  • Engineering Immunity Before the Outbreak

  • Protecting Tomorrow’s World, Today

Thermostable Platform

VaxFarm™ patented thermostable platform provides improved thermostability for last mile delivery

Know more

Combination Vaccines

VaxFarm™ aims to make a significant difference in global health through our innovative vaccine solutions.

Vaccine Development

VaxFarm™ develops innovative vaccines for current and emerging infectious diseases using advanced and AI-driven technologies.

At VaxFarm, we dedicate ourselves to developing groundbreaking vaccines that address the health needs of communities globally. Our team of experts drives innovation in biotechnology.

Engineering Immunity Before the Outbreak

Product Pipeline

Chikungunya Vaccine

  • Market valued at approximately $605.74 million in 2025,

  • Market projected to grow to nearly $980 million by 2032.

  • Primary market in endemic regions (Africa, Asia, Latin America)

Chikung.jpeg

Hepatitis E Vaccine

  • HEV included in Gavi's 2026–2030 Investment Strategy.

  • Major upcoming surge in low-income countries.

  • Only one vaccine licensed globally.

Hep E.png

Combination Vaccine for SPV, GPV & PPR

  • A single dose of the combined vaccine can provide long-lasting immunity, upto 3 years.

  • Sheep Pox & Goat Pox lead to economic losses of $48 million per year across Africa, Middle East, and Asia.

combo.png

$5B+

of vaccine Opportunity

Over the past five years, VaxFarm has built a strong portfolio of vaccine assets targeting infectious diseases, driven by a clear vision to combat future pandemics.

Today, that focus is delivering results, with multiple vaccine candidates advancing toward clinical development—positioning Vaxfarm to create meaningful impact for patients and long-term value for stakeholders.

Australian office

R&D Facility

New Delhi, India

Research & Innovation Park

Indian Institute of Technology Delhi

VaxFarm’s R&D facility is strategically located in New Delhi, fostering innovation within the state-of-the-art Biotechnology Business Incubation Facility at the Indian Institute of Technology Delhi.

Sydney, Australia

VaxFarm's Australian office is located in Sydney CBD, fostering innovation at the heart of Tech Central Innovation Precinct.

Get in Touch

For inquiries regarding investment, partnerships, or collaborative opportunities, we welcome you to contact us.

We look forward to engaging with industry leaders to advance innovation and shared value creation.

Contact us

bottom of page